Search

for
Search:

Sort by

Research

90-101 / 101 results

Sustainable UV Approaches Supported by Greenness and Whiteness Assessments for Estimating a Recently FDA-Approved Combination for Managing Urologic Disorders: Tukey's Test

research Sustainable UV Approaches Supported by Greenness and Whiteness Assessments for Estimating a Recently FDA-Approved Combination for Managing Urologic Disorders: Tukey's Test

October 2023 in “Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy”

New, eco-friendly methods accurately measure TDF and FNS in a new urologic medication.

research Clinical Review of Ejaculatory Dysfunction

24 citations, July 2019 in “Reproductive Medicine and Biology”

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

research Platelet-Rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

20 citations, April 2023 in “The Journal of Urology”

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire and Function in Women

research FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire and Function in Women

April 2020 in “Online journal of complementary & alternative medicine”

Some medications can help increase sexual desire and function in women.

research Consequences of Anabolic-Androgenic Steroid Abuse in Males: Sexual and Reproductive Perspective

19 citations, June 2021 in “The world journal of men's health”

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

research Diagnostic Criteria for Enduring Sexual Dysfunction After Treatment With Antidepressants, Finasteride, and Isotretinoin

8 citations, October 2021 in “The international journal of risk and safety in medicine”

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

research Clinical Pearls in Men's Health

1 citations, June 2010 in “Mayo Clinic Proceedings”

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

research The North American Menopause Society Recommendations for Clinical Care of Midlife Women

254 citations, September 2014 in “Menopause”

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

research Persistent Erectile Dysfunction in Men Exposed to 5α-Reductase Inhibitors, Finasteride, or Dutasteride

50 citations, March 2017 in “PeerJ”

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

research The Optimal Indication for Testosterone Replacement Therapy in Late-Onset Hypogonadism

17 citations, February 2019 in “Journal of Clinical Medicine”

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Anti-Inflammatory Effects in LPS-Treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-San

research Anti-Inflammatory Effects in LPS-Treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-San

December 2021 in “Daehanhanuihakoeji”

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

← Previous page